Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Uni-Bio Science GroupUNBSF 58 Days Payable is 79.24 as of Dec. 2025, which is 85% above its 10-year median of 42.94. GuruFocus rates UNBSF with a GF Score™ of 58/100 and a GF Value™ of $0.01. The stock has 3 warning signs investors should review. Among 703 Biotechnology companies, Uni-Bio Science Group ranks worse than 62.3% on this metric.
Uni-Bio Science Group Days Payable Historical Data
* Premium members only.
The historical data trend for Uni-Bio Science Group's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
UNBSF vs VRTX, REGN, RVMD: Days Payable Comparison
For the Biotechnology subindustry, Uni-Bio Science Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Uni-Bio Science Group Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Uni-Bio Science Group's Days Payable distribution charts can be found below:
* The bar in red indicates where Uni-Bio Science Group's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Uni-Bio Science Group's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Uni-Bio Science Group (UNBSF) has a Days Payable of 79.24 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Uni-Bio Science Group and its competitors. This is 85% above median its historical median of 42.94. Over the past decade, Uni-Bio Science Group's Days Payable has ranged from 12.34 to 129.31. According to the industry distribution chart, Uni-Bio Science Group ranks #438 out of 703 companies in the Biotechnology industry, placing it in the top 62.3%.
Is Uni-Bio Science Group's Days Payable too high?
Uni-Bio Science Group's current Days Payable of 79.24 is 85% above median its 10-year median of 42.94. Over the past 10 years, this metric has ranged from a low of 12.34 to a high of 129.31. The Biotechnology industry median Days Payable is 110.14. Uni-Bio Science Group's value of 79.24 is 28.1% below this industry median. Based on the distribution chart, Uni-Bio Science Group ranks #438 out of 703 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Uni-Bio Science Group has a GF Score™ of 58/100, reflecting its overall financial health beyond just this single metric.
How does Uni-Bio Science Group's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Uni-Bio Science Group ranks #438 out of 703 companies for Days Payable. This places Uni-Bio Science Group in the lower half of its industry. The industry median Days Payable is 110.14. Uni-Bio Science Group's value of 79.24 is 28.1% below this benchmark. Historically, Uni-Bio Science Group's own Days Payable has ranged from 12.34 to 129.31 over the past decade. While the company's 10-year median is 42.94 vs. the industry median of 110.14, Uni-Bio Science Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 110.14, based on 703 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Uni-Bio Science Group's current Days Payable of 79.24 is 28.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Uni-Bio Science Group and its competitors. For the Biotechnology industry, the median Days Payable is 110.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Uni-Bio Science Group's current Days Payable is 79.24, which is 85% above median its own 10-year median of 42.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Uni-Bio Science Group stock overvalued right now?
Uni-Bio Science Group (UNBSF) has a current Days Payable of 79.24. The stock's GF Value™ is $0.01, compared to a current price of $0.00 — trading 60% below its estimated fair value. The current Days Payable is 79.24, which is 85% above median its 10-year median of 42.94 and 28.1% below the Biotechnology industry median of 110.14. Uni-Bio Science Group's overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Uni-Bio Science Group (UNBSF), the current Days Payable is 79.24 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Uni-Bio Science Group (UNBSF) Overvalued in 2026?
Based on GuruFocus' analysis, Uni-Bio Science Group stock appears to be undervalued.
The current stock price of $0.00 is trading 60% below its estimated GF Value™ of $0.01.
Key valuation signals for UNBSF:
Days Payable: 79.24 (85% above median its 10-year median of 42.94)
GF Value™: $0.01 vs. price of $0.00 (60% below fair value)
Industry Position: 28.1% below the Biotechnology median (#438 of 703)
No single metric tells the full story. See the UNBSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Uni-Bio Science Group Ltd is an investment holding company. It operates in three segments: Chemical pharmaceutical products, Biological pharmaceutical products, and Pipeline products. Its geographical segments are Hong Kong and China, of which all of its revenue comes from China. The company products include GeneSoft, GeneTime, Pinup, Boshutai, Bokangtai, and others. All of the company revenue is generated from PRC.
58GF Score
Get the complete analysis for UNBSF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
UNBSF has been successfully added to your 
